Zicheng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zicheng Wang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Qinghua Xia
Department of Urology Shandong Provincial Hospital Shandong First Medical University & Shandong Academy of Medical Sciences Jinan Shandong China
2 shared publications - Yingkun Xu
Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China
2 shared publications Chen Chen
Department of Urology, Liaocheng People's Hospital, Shandong University 252000, China
1 shared publicationDengke Nie
Department of Chest Surgery, The First Affiliated Hospital of Henan University, Kaifeng 475001, China
1 shared publicationGuangzhen Wu
Department of Urology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China
1 shared publicationJiechuan Qiu
Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China
1 shared publication
Latest Publications
- 7 January 2025
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 23, 1
WITHDRAWN: Comprehensive Analysis of the Role of CXCL Family Members in Clear Cell Renal Cell Carcinoma
Since the authors are not responding to the editor’s requests to fulfill the editorial requirement, therefore, the article has been withdrawn from the journal Current Cancer Drug Targets. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php BENTHAM SCIENCE DISCLAIMER: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultane-ously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submit-ting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
- 7 January 2025
- Published by Bentham Science Publishers Ltd. in Current Cancer Drug Targets
- Vol. 23, 1
WITHDRAWN: Comprehensive Analysis of the Role of CXCL Family Members in Clear Cell Renal Cell Carcinoma
Since the authors are not responding to the editor’s requests to fulfill the editorial requirement, therefore, the article has been withdrawn from the journal Current Cancer Drug Targets. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php BENTHAM SCIENCE DISCLAIMER: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultane-ously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submit-ting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
- Open Access
- 5 July 2023
- Published by Elsevier in Pathology - Research and Practice
- Vol. 248, 154641
Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma
- 5 July 2023
- Published by Elsevier in Pathology - Research and Practice
- Vol. 248, 154641
Open AccessSphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma